A Phase 1, Open-Label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]Varegacestat Following a Single Oral Dose in Healthy Adult Male Participants
Latest Information Update: 03 Mar 2025
At a glance
- Drugs BMS 986115 (Primary)
- Indications Fibroma
- Focus Pharmacokinetics
- Sponsors Immunome
- 03 Mar 2025 New trial record